CannaMore Biotechs
An innovation R&D platform company for cannabis based drug developments
An innovation R&D platform company for cannabis based drug developments
Variety of different IP based Cannabinoid ventures in different fields
Partners with the largest HMO in Israel + first look right
Potential distribution and sales in both long term pharmaceutical and short term wellness
Founder & CEO
A leading Experienced and proficient entrepreneur. Main Shareholder in multiple startups. Previously founder of a series of ventures to EXIT in the Hi tech and Biotech industries.
CFO
Experienced in Public and Private, Multi Millions & Start Ups companies with extensive experience in business & finance. Ofer has vast experience in fundraising from Angel investors & funds.
VP BizDev
A managing partner & co-founder of Danbar Group Ltd., Director at. Serves as the Director at Redhill Biopharma, Maabarot products and many other companies. Served as CEO & chairman at private and publicly traded companies.
COO
Experienced and active executive in multiple startup companies in various Biotech & technologies fields. Graduated B.Sc. in Biology and life science at Tel Aviv University with specialty in biochemistry.
Scientific & Medical Consultant
Vast medical experience with an international reputation. Served as Chairman, Department of Medicine and a Hematology Consultant at the Tel Aviv Sourasky (Ichilov) Medical Center. Proficient and experienced with multiple medical and health technologies and fields.
Senior Scientific Advisor
Over 20 years of proven management experience in the fields of clinical development, business development, marketing and intellectual property from the bio-tech and high-tech industries. The pharma and diagnostics department at Mor Research Applications, the Technology Transfer unit of ‘CLALIT’ Health Services. Holds a PhD in immunology and an MBA from Tel Aviv University.
Senior Medical Advisor
Specialist in Internal Medicine, Hematology and Bone Marrow Transplantation. Director of the Bone Marrow Transplantation Unit at Rabin Medical Center, Israel. The inventor of a CBD based drug and IP for treatment of GvHD, sold to publicly traded Kalytera Therapeutics (TSXV: KALY).
This strategic groundbreaking partnership allows us to enjoy:
Under Clalit are:
© CannaMore Biotechs Ltd. 2018, All Rights Reserved. | Email: Contact@TalentFund.co.il